Study on measles protection in children
Part of Infections clinical trials.
This study looks at how measles affects children differently based on whether they have been vaccinated or had the infection before. It aims to understand why some children get very sick and others don't.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 4 and 17 years old
- Either have never had the measles vaccine or infection (Group A) OR have been vaccinated or had measles before (Group B)
- No chronic illness lasting more than 3 months
- No immune system problems from medicine or other disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system responds to measles infection or vaccination in adults. It may help explain why some people develop stronger immunity than others.
This study looks at how babies’ immune systems develop in early life and how they respond to immunization. It compares preterm infants with full-term infants whose mothers received Tdap during pregnancy, to learn what protection and immune responses to expect.
This study checks if the measles vaccine works well in children with sickle cell disease. It aims to help protect children with this condition from measles.
This trial offers a measles vaccine to children who have not had full measles shots, timed around visits to a children’s hospital. It aims to see whether vaccinating children at these health care contacts helps improve protection against measles.
This study tests whether changing the measles vaccine timing in 6-month-old children can reduce allergy risk and also help protect against unrelated infections. If your child is already up to date with routine vaccines, they may be eligible for a modified measles (MMR) schedule used in the trial.
This study checks how well adults stay protected against measles after they receive a donor bone marrow transplant. It helps doctors understand measles immune status and may guide future protection for transplant recipients.
Hear when a new MEASLES DISEASE trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.